HERON THERAPEUTICS, INC.

Heron Therapeutics, Inc. specializes in the manufacturing of pharmaceutical preparations, with demonstrated expertise in the development and production of complex drug formulations, including hematological and specialty therapeutics. The company’s technical capabilities encompass GMP-compliant manufacturing processes, sterile drug product assembly, and regulatory-compliant supply chain management for federally procured medications. Their focus on pharmaceutical preparation aligns with the stringent quality and consistency requirements of government healthcare procurement, particularly for controlled and high-potency agents used in clinical settings. The company’s operational model emphasizes precision formulation, batch traceability, and adherence to FDA and VA-specific pharmaceutical standards, positioning them as a reliable source for mission-critical drug products. The contractor has delivered pharmaceutical products under a Federal Supply Schedule contract awarded by the Department of Veterans Affairs, indicating direct engagement with VA medical facilities and pharmacy networks. This relationship suggests experience supplying drugs for veteran-specific treatment protocols, including oncology, hematology, and chronic disease management. The nature of the award implies ongoing collaboration with VA procurement and clinical pharmacy teams to ensure timely, compliant delivery of essential medications. The primary NAICS code 325412 reflects core competency in the manufacturing of finished pharmaceutical dosage forms, including tablets, injectables, and other pre-packaged therapeutics. The company operates within the federal pharmaceutical supply chain, serving specialized medical needs where regulatory rigor and supply reliability are paramount. Their market positioning centers on niche pharmaceutical manufacturing rather than broad-scale production, targeting government agencies requiring controlled, high-integrity drug products. Heron Therapeutics, Inc. is a small business entity headquartered in San Diego, California, with no disclosed federal certifications. Its geographic presence supports West Coast logistics networks, enabling efficient distribution to federal medical centers. The company’s business profile reflects a focused, manufacturing-driven approach to serving government health systems through compliant, high-quality pharmaceutical output.